22.728 articles found

Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.

Chinnapongse R, Gullo K, Nemeth P, Zhang Y, Griggs L.

Mov Disord · 2011-09-01

DOI: 10.1002/mds.23929PMID: 21887710

Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal.

Kanwar JR, Sun X, Punj V, Sriramoju B, Mohan RR, Zhou SF, Chauhan A, Kanwar RK.

Nanomedicine · 2011-09-01

DOI: 10.1016/j.nano.2011.08.006PMID: 21889479

The CDK inhibitors in cancer research and therapy.

Cicenas J, Valius M.

J Cancer Res Clin Oncol · 2011-08-30

DOI: 10.1007/s00432-011-1039-4PMID: 21877198

KASPP (LRRK2) GENE, ITS PRODUCTION AND USE FOR THE DETECTION AND TREATMENT OF NEURODEGENERATIVE DISORDERS

MEITINGER THOMAS, STROM TIM MATTHIAS, BISKUP SASKIA, UEFFING MARIUS, KREMMER ELISABETH, GLOECKNER CHRISTIAN JOHANNES, GASSER THOMAS, HERZIG PETRA LEITNER, ASMUS FRIEDRICH, PATENGE NADJA, ZIMPRICH ALEXANDER, FARRER MATTHEW J, KACHERGUS JENNIFER M, LINCOLN SARA J, HULIHAN MARY M, WSZOLEK ZIBIGNIEW, UITTI RYAN.

· 2011-08-26

An autoradiographic study on the pathogenesis of levodopa-induced dyskinesia: regulation of dopamine transporter by levodopa in a rat model of Parkinson's disease.

Cai XY, Kong XM, Fang Q, Ning P, Xu YJ, Zhang B, Xue SR.

Neurodegener Dis · 2011-08-26

DOI: 10.1159/000328816PMID: 21876323

Neuroprotection in metabolism-based therapy.

Hartman AL.

Epilepsy Res · 2011-08-26

DOI: 10.1016/j.eplepsyres.2011.04.016PMID: 21872441

Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.

Ceballos-Baumann A, Häck HJ.

Curr Med Res Opin · 2011-08-25

DOI: 10.1185/03007995.2011.611630PMID: 21867400

Chronic progesterone treatment of male rats with unilateral 6-hydroxydopamine lesion of the dorsal striatum exacerbates [corrected] parkinsonian symptoms.

Chao OY, Huston JP, von Bothmer A, Pum ME.

Neuroscience · 2011-08-25

DOI: 10.1016/j.neuroscience.2011.08.043PMID: 21888950

Reversible Pisa syndrome in patients with Parkinson's disease on rasagiline therapy.

Fasano A, Di Matteo A, Vitale C, Squintani G, Ferigo L, Bombieri F, Santangelo G, Amboni M, Barone P, Tinazzi M.

Mov Disord · 2011-08-24

DOI: 10.1002/mds.23918PMID: 22170277

Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.

Liedhegner EA, Steller KM, Mieyal JJ.

Chem Res Toxicol · 2011-08-22

DOI: 10.1021/tx200082hPMID: 21815648

Kynurenines in Parkinson's disease: therapeutic perspectives.

Zádori D, Klivényi P, Toldi J, Fülöp F, Vécsei L.

J Neural Transm (Vienna) · 2011-08-20

DOI: 10.1007/s00702-011-0697-3PMID: 21858430

Novel Therapeutic Compounds

SESHA RAMESH.

· 2011-08-19